Patrick Davies

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In
Patrick Davies
Non-Executive Director, Non-Executive Chairman / Neuren Pharmaceuticals
Mr Davies' experience includes 10 years as CEO of EBOS Group (formerly Symbion). He provides strategic advice to a range of healthcare businesses and investors.

Lists and Charts

Total Shareholder Return as at 31/10/24

RankCompany1 yr5 yr
655thNeuren Pharmaceuticals15%40%
View Full List
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

24/06/21
$61k Bought
Neuren Pharmaceuticals
17/02/21
$50k Bought
Neuren Pharmaceuticals
07/08/20
$30k Bought
Neuren Pharmaceuticals
Total value as at the date of the transaction
Powered by Morningstar ®

Revenue

RankCompanyRevenue
th-Neuren Pharmaceuticals$234.4m
View Full List
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®

Person Activity

Default
NEW ROLE: Non-Executive Director, Non-Executive Chairman, Neuren Pharmaceuticals03 Nov 2020

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options